Article (Scientific journals)
BRCA1 germline mutation and glioblastoma development: report of cases
Boukerroucha, Meriem; Josse, Claire; SEGERS, Karin et al.
2015In BMC Cancer, 15, p. 181
Peer Reviewed verified by ORBi
 

Files


Full Text
2015 - BRCA1 germline mutation and glioblastoma development report of cases - BMC Cancer.pdf
Publisher postprint (2.56 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
BRCA1; Glioblastoma; Breast Cancer
Abstract :
[en] Background Germline mutations in breast cancer susceptibility gene 1 (BRCA1) increase the risk of breast and ovarian cancers. However, no association between BRCA1 germline mutation and glioblastoma malignancy has ever been highlighted. Here we report two cases of BRCA1 mutated patients who developed a glioblastoma (GBM). Cases presentation Two patients diagnosed with triple negative breast cancer (TNBC) were screened for BRCA1 germline mutation. They both carried a pathogenic mutation introducing a premature STOP codon in the exon 11 of the BRCA1 gene. Few years later, both patients developed a glioblastoma and a second breast cancer. In an attempt to clarify the role played by a mutated BRCA1 allele in the GBM development, we investigated the BRCA1 mRNA and protein expression in breast and glioblastoma tumours for both patients. The promoter methylation status of this gene was also tested by methylation specific PCR as BRCA1 expression is also known to be lost by this mechanism in some sporadic breast cancers. Conclusion Our data show that BRCA1 expression is maintained in glioblastoma at the protein and the mRNA levels, suggesting that loss of heterozygosity (LOH) did not occur in these cases. The protein expression is tenfold higher in the glioblastoma of patient 1 than in her first breast carcinoma, and twice higher in patient 2. In agreement with the high protein expression level in the GBM, BRCA1 promoter methylation was not observed in these tumours. In these two cases, despite of a BRCA1 pathogenic germline mutation, the tumour-suppressor protein expression is maintained in GBM, suggesting that the BRCA1 mutation is not instrumental for the GBM development.
Research center :
GIGA‐R - Giga‐Research - ULiège
Disciplines :
Oncology
Author, co-author :
Boukerroucha, Meriem ;  Université de Liège > Département des sciences biomédicales et précliniques > GIGA-R : Génétique humaine
Josse, Claire  ;  Université de Liège > Département des sciences biomédicales et précliniques > GIGA-R : Génétique humaine
SEGERS, Karin ;  Centre Hospitalier Universitaire de Liège - CHU > Génétique
El Guendi, Sonia ;  Université de Liège > Département des sciences biomédicales et précliniques > GIGA-R : Génétique humaine
FRERES, Pierre ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Bours, Vincent ;  Université de Liège > Département des sciences biomédicales et précliniques > GIGA-R : Génétique humaine
Language :
English
Title :
BRCA1 germline mutation and glioblastoma development: report of cases
Publication date :
26 March 2015
Journal title :
BMC Cancer
eISSN :
1471-2407
Publisher :
BioMed Central
Volume :
15
Pages :
181
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
DGTRE - Région wallonne. Direction générale des Technologies, de la Recherche et de l'Énergie [BE]
FIRS - CHU Liège. Fonds d'Investissement de Recherche Scientifique [BE]
Available on ORBi :
since 18 June 2015

Statistics


Number of views
107 (11 by ULiège)
Number of downloads
169 (6 by ULiège)

Scopus citations®
 
24
Scopus citations®
without self-citations
23
OpenCitations
 
15

Bibliography


Similar publications



Contact ORBi